Delivery Order SPE2DB24D1205-SPE2DB25FCZVQ
Award Date 8/25/25
Potential Completion Date 9/16/25
Potential Value $8.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,118.08 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ibrance 125 mg capsules (21-count packaging). This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The order is scheduled for completion by October 9, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ibrance 75 mg capsules (21-count packages) valued at $8,123.96 with an ultimate completion date of September 26, 2025. This contract represents a firm fixed-price delivery order under a non-set-aside competitive procurement, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Ibrance is a prescription pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ibrance 125 mg capsules (21-count units) with a ceiling value of $8,118.08. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is expected to be completed by October 8, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ibrance 125 mg tablets in a quantity of seven units, with a ceiling value of $8,118.08. This firm fixed-price delivery order, which is expected to be completed by September 10, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $8,118.08 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ibrance 125 mg capsules (21-count packages). This firm fixed-price, competitively awarded contract is scheduled for completion by October 20, 2025, and represents performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award carries no set-aside designation and is issued as a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,118.08 to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg capsules (21-count package) under a firm fixed price contract. The award was issued on September 8, 2025, with an ultimate completion date of September 29, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ibrance 125 mg capsules (21-count packaging) with a contract value of $8,118.08. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The order is expected to be completed by September 30, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ibrance 100 mg capsules (21-count) with a ceiling value of $8,122.48. This firm fixed-price delivery order, which must be completed by September 16, 2025, is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Ibrance 100 mg capsules (21-count packages) with a ceiling value of $8,122.48. This firm fixed-price delivery order, which is expected to be completed by June 24, 2025, carries no set-aside designation and represents a competitively awarded contract. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a $16,244.96 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ibrance 100 mg capsules (21-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by October 20, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...